Latest Breaking News On - Angelos stergiou - Page 5 : comparemela.com

SELLAS Life Sciences (SLS) Reports Positive Follow-Up Immune Response and Survival Data in Completed Phase 1 Study of Galinpepimut-S Combined with Opdivo

SELLAS Life Sciences (SLS) Reports Positive Follow-Up Immune Response and Survival Data in Completed Phase 1 Study of Galinpepimut-S Combined with Opdivo
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Angelos-stergiou
National-cancer-institute
Nasdaq
Sellas-life-sciences-group-inc
Sciences-group
Wilms-tumor

SELLAS Life Sciences Reports Positive Follow-Up Immune Response and Survival Data in Completed ...

-Primary Endpoint of Safety and Efficacy Met with Clinical Activity and Increased Survival Observed -

China
United-states
Bruce-mackle
Angelos-stergiou
Life-sciences-group-inc
National-cancer-institute
Nasdaq
Genfleet-therapeutics-shanghai-inc
Memorial-sloan-kettering-cancer-center
Bristol-myers-squibb
Lifesci-advisors
Primary-endpoint

SELLAS Life Sciences Reports Positive Follow-Up Immune Response and Survival Data in Completed Phase 1 Study of Galinpepimut-S Combined with Opdivo® in Advanced Malignant Pleural Mesothelioma

SELLAS Life Sciences Reports Positive Follow-Up Immune Response and Survival Data in Completed Phase 1 Study of Galinpepimut-S Combined with Opdivo® in Advanced Malignant Pleural Mesothelioma
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

China
United-states
Bruce-mackle
Angelos-stergiou
National-cancer-institute
Life-sciences-reports-positive
Life-sciences-group-inc
Memorial-sloan-kettering-cancer-center
Bristol-myers-squibb
Genfleet-therapeutics-shanghai-inc
Nasdaq
Lifesci-advisors

SELLAS receives orphan drug designation for PTCL therapy

SELLAS has received ODD from the US FDA for SLS009, a new CDK9 inhibitor aimed at treating relapsed/refractory Peripheral T-cell Lymphomas (PTCL).

China
Angelos-stergiou
Genfleet-therapeutics

SELLAS Life Sciences (SLS) Granted FDA Orphan Drug Designation for SLS009

SELLAS Life Sciences (SLS) Granted FDA Orphan Drug Designation for SLS009
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

China
United-states
Angelos-stergiou
Drug-administration
Office-of-orphan-products-development
Genfleet-therapeutics-inc
Sellas-life-sciences-group-inc
Nasdaq
Sciences-group
Orphan-drug-designation
Peripheralt-cell-lymphomas
Fast-track-designation